3,628 Shares in Merit Medical Systems, Inc. (NASDAQ:MMSI) Purchased by CreativeOne Wealth LLC

CreativeOne Wealth LLC purchased a new position in Merit Medical Systems, Inc. (NASDAQ:MMSI) in the 4th quarter, according to the company in its most recent disclosure with the Securities and Exchange Commission. The institutional investor purchased 3,628 shares of the medical instruments supplier’s stock, valued at approximately $276,000.

A number of other hedge funds and other institutional investors have also recently modified their holdings of MMSI. M&T Bank Corp increased its holdings in shares of Merit Medical Systems by 65.0% in the 4th quarter. M&T Bank Corp now owns 29,223 shares of the medical instruments supplier’s stock valued at $2,219,000 after acquiring an additional 11,512 shares during the period. Public Employees Retirement System of Ohio raised its holdings in Merit Medical Systems by 69.3% in the third quarter. Public Employees Retirement System of Ohio now owns 103,099 shares of the medical instruments supplier’s stock worth $7,116,000 after purchasing an additional 42,191 shares in the last quarter. Dimensional Fund Advisors LP lifted its position in shares of Merit Medical Systems by 3.2% during the fourth quarter. Dimensional Fund Advisors LP now owns 1,306,702 shares of the medical instruments supplier’s stock valued at $99,258,000 after buying an additional 41,065 shares during the last quarter. Mesirow Institutional Investment Management Inc. grew its position in shares of Merit Medical Systems by 10.7% in the 4th quarter. Mesirow Institutional Investment Management Inc. now owns 134,016 shares of the medical instruments supplier’s stock worth $10,180,000 after buying an additional 12,971 shares during the last quarter. Finally, FMR LLC grew its position in shares of Merit Medical Systems by 26.0% in the 3rd quarter. FMR LLC now owns 607,881 shares of the medical instruments supplier’s stock worth $41,956,000 after buying an additional 125,605 shares during the last quarter. 99.66% of the stock is currently owned by institutional investors.

Merit Medical Systems Stock Performance

NASDAQ:MMSI traded up $1.02 during mid-day trading on Friday, hitting $81.92. The company’s stock had a trading volume of 213,820 shares, compared to its average volume of 382,955. The business’s fifty day moving average is $75.91 and its two-hundred day moving average is $75.58. The stock has a market cap of $4.76 billion, a price-to-earnings ratio of 47.08, a PEG ratio of 2.26 and a beta of 0.91. Merit Medical Systems, Inc. has a 1 year low of $62.58 and a 1 year high of $85.62. The company has a debt-to-equity ratio of 0.65, a current ratio of 6.03 and a quick ratio of 4.38.

Merit Medical Systems (NASDAQ:MMSI) last announced its quarterly earnings results on Tuesday, April 30th. The medical instruments supplier reported $0.77 earnings per share for the quarter, beating the consensus estimate of $0.71 by $0.06. Merit Medical Systems had a return on equity of 15.02% and a net margin of 7.94%. The company had revenue of $323.51 million during the quarter, compared to analysts’ expectations of $315.57 million. During the same period last year, the business earned $0.64 earnings per share. Merit Medical Systems’s quarterly revenue was up 8.7% on a year-over-year basis. Analysts anticipate that Merit Medical Systems, Inc. will post 3.33 EPS for the current fiscal year.

Analyst Ratings Changes

Several research firms have issued reports on MMSI. CL King assumed coverage on shares of Merit Medical Systems in a report on Thursday, April 11th. They issued a “buy” rating and a $88.00 price target on the stock. Piper Sandler boosted their price target on Merit Medical Systems from $95.00 to $97.00 and gave the stock an “overweight” rating in a research note on Wednesday, May 1st. Raymond James increased their price objective on shares of Merit Medical Systems from $84.00 to $89.00 and gave the company an “outperform” rating in a research report on Tuesday, January 30th. Oppenheimer upped their price target on shares of Merit Medical Systems from $82.00 to $87.00 and gave the company an “outperform” rating in a research note on Thursday, February 29th. Finally, Bank of America initiated coverage on shares of Merit Medical Systems in a report on Wednesday, February 7th. They set a “neutral” rating and a $87.00 price objective on the stock. One research analyst has rated the stock with a hold rating and nine have given a buy rating to the stock. According to data from MarketBeat.com, the stock has an average rating of “Moderate Buy” and a consensus price target of $92.78.

Insiders Place Their Bets

In related news, CFO Raul Jr. Parra sold 6,480 shares of Merit Medical Systems stock in a transaction dated Tuesday, March 12th. The stock was sold at an average price of $73.95, for a total value of $479,196.00. Following the completion of the transaction, the chief financial officer now owns 12,007 shares in the company, valued at approximately $887,917.65. The sale was disclosed in a document filed with the SEC, which is available through the SEC website. In related news, insider Joseph Wright sold 25,000 shares of the company’s stock in a transaction dated Thursday, March 7th. The shares were sold at an average price of $75.68, for a total transaction of $1,892,000.00. Following the completion of the transaction, the insider now owns 42,223 shares in the company, valued at approximately $3,195,436.64. The transaction was disclosed in a legal filing with the SEC, which can be accessed through the SEC website. Also, CFO Raul Jr. Parra sold 6,480 shares of Merit Medical Systems stock in a transaction dated Tuesday, March 12th. The stock was sold at an average price of $73.95, for a total value of $479,196.00. Following the completion of the sale, the chief financial officer now owns 12,007 shares in the company, valued at $887,917.65. The disclosure for this sale can be found here. Over the last quarter, insiders sold 49,637 shares of company stock worth $3,751,673. Company insiders own 3.70% of the company’s stock.

Merit Medical Systems Company Profile

Merit Medical Systems, Inc designs, develops, manufactures, and markets single-use medical products for interventional, diagnostic, and therapeutic procedures in the United States and internationally. It operates in two segments, Cardiovascular and Endoscopy. The company provides micropuncture kits, angiographic needles, sheaths, guide wires, and safety products; peripheral intervention, including angiography, drainage, delivery systems, and embolotherapy products; spine products, such as vertebral augmentation, radiofrequency ablation, and bone biopsy systems; oncology products; and cardiac intervention products, such as access, angiography, electrophysiology and cardiac rhythm management, fluid management, hemodynamic monitoring, hemostasis, and intervention to treat various heart conditions.